WAUSAU, Wis. (WSAU) –Marshfield Clinic is looking for a handful of diabetes patients to participate in a national study that could help doctors better control the disease.
The study will look at whether adding setagliptin to a combination treatment for Type 2 diabetes patients will provide a better outcome for complications such as kidney failure and permanent and irreversible eye and nerve damage.
“If we can do multi-drug combinations to keep the diabetes under better control, we may have better outcomes for patients in the long run,” said Dr. Anshu Varma,, who is helping conduct the research.
Participants must have a hemoglobin A1C reading between 7.5 and 11 and be taking a combination treatment with one of the dugs being metformin in order to be eligible. To see if you’re eligible, you can call clinical research coordinators in either Weston or Marshfield. The Weston contact is Paula Mueller at 715-393-1335. The Marshfield contact is Katie Moore at 715-389-3632.
Those who qualify for the randomized, double-blind study will receive a combination of metformin and pioglitazone along with either sitagliptin or a placebo. They will also receive study-related car and medication at no charge for 26 weeks.
The study is being sponsored by the New Jersey-based drug maker Merck.
